Cortese, Samuele, Kim, Min Seo, Han, Jong Hoon, Oh, Sarah Soyeon, Yon, Dong Keon, Shin, Jae Il and Solmi, Marco (2026) Incidence, prevalence, and global burden of attention-deficit/hyperactivity disorder from 1990 to 2021 across 204 countries in individuals under age 20: data, with critical appraisal, from the 2021 Global Burden of Disease study. Molecular Psychiatry, 31 (10), 5931-5940. (doi:10.1038/s41380-026-03683-4).
Abstract
Importance: estimating the global and national incidence, prevalence, and burden of attention-deficit/hyperactivity disorder (ADHD) in children and young people is relevant for informing public health initiatives.
Objective: to report and discuss the global and national incidence, prevalence, and burden of ADHD in children and young people according to the 2021 Global Burden of Disease Study (GBD) 2021.
Design, setting, and Participants: This was a global population-based study using data from GBD 2021, encompassing 204 countries and territories. The analysis included children and youths under 20 years of age with ADHD.
Exposure: ADHD among children and youths under 20 years of age, evaluated from 1990 to 2021.
Main outcome measures: incidence, prevalence, and disability-adjusted life years (DALYs).
Results: globally in 2021, there were a total of 46,890,733 (95% uncertainty interval [UI]: 32,136,904 to 67,271,064) prevalent cases and 4,111,621 (2,775,203 to 5,954,941) incident cases of ADHD in individuals under 20 years old. ADHD caused a total of 574,979 (294,277 to 977,557) DALYs. The prevalence and incidence rates of ADHD were 1.78% (1.22% to 2.55%) and 0.16% (0.11% to 0.23%), respectively. The DALY rate of ADHD was 21.8 (11.2 to 37.1) per 100,000 population. In 2021, prevalence (5.62%, 95% UI: 4.16% to 7.46%) and incidence (0.49%, 95% UI: 0.34% to 0.66%) were highest in Australia. From 1990 to 2021, the global prevalence and incidence rates decreased by 6% (95% UI: −8.48 to −3.45) and 5.81% (95% UI: −8.21 to −3.04), respectively. Prevalence was consistently higher in males than in females across all GBD regions [males: 2.52% (1.72 to 3.62); females, 0.99% (0.68 to 1.44)]. Prevalence was higher with increasing socio-demographic index (SDI) ([2.88% (95% UI 1.94 to 4.09)] in the highest SDI subgroup).
Conclusions and relevance: the GBD 2021 represent the most comprehensive source for the global prevalence, incidence, and burden of ADHD. These findings can inform policymakers and stakeholders. However, due to potential methodological issues, the GBD data may have underestimated the prevalence, incidence, and burden of ADHD.
More information
Identifiers
Catalogue record
Export record
Altmetrics
Contributors
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
